Kymera Therapeutics, Inc. · NASDAQ:KYMR
T. Rowe Price Investment Management, Inc. reported a 6.70% stake in Kymera Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Investment Management, Inc. reported a 6.70% stake in Kymera Therapeutics, Inc., 5,460,257 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 5,460,257
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.70% | 5,460,257 |
Source
Related
- Kymera Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026